Runben Biotechnology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 16.66% vs 20.09% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -2.97% vs 31.97% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "342.40",
          "val2": "293.50",
          "chgp": "16.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "84.50",
          "val2": "88.10",
          "chgp": "-4.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "78.50",
          "val2": "80.90",
          "chgp": "-2.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "246.80%",
          "val2": "281.90%",
          "chgp": "-3.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 27.39% vs 20.78% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.83% vs 41.25% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,308.30",
          "val2": "1,027.00",
          "chgp": "27.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "329.40",
          "val2": "264.60",
          "chgp": "24.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "300.20",
          "val2": "226.00",
          "chgp": "32.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "235.50%",
          "val2": "236.30%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

342.40

293.50

16.66%

Operating Profit (PBDIT) excl Other Income

84.50

88.10

-4.09%

Interest

0.00

0.00

Exceptional Items

-0.40

0.00

Consolidate Net Profit

78.50

80.90

-2.97%

Operating Profit Margin (Excl OI)

246.80%

281.90%

-3.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 16.66% vs 20.09% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -2.97% vs 31.97% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,308.30

1,027.00

27.39%

Operating Profit (PBDIT) excl Other Income

329.40

264.60

24.49%

Interest

0.20

0.40

-50.00%

Exceptional Items

3.60

0.00

Consolidate Net Profit

300.20

226.00

32.83%

Operating Profit Margin (Excl OI)

235.50%

236.30%

-0.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 27.39% vs 20.78% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 32.83% vs 41.25% in Dec 2023

All Annual Results